Sophie Kornowski

Dr. Sophie Kornowski was appointed Chief Executive Officer and Chair of the Board of Boston Pharmaceuticals in 2022. Since 2018, Sophie has been a partner at Gurnet Point Capital, a private investment firm focused on the healthcare sector. In this role, she worked closely with the Boston Pharmaceuticals team for several years, as a member of the Board of Directors and, at the request of the Board, has been supporting Corporate Development efforts.

In her position at Gurnet Point Capital, Dr. Kornowski has been a successful investor in several innovative start-ups and high-growth businesses that have products in the clinic or commercialize, diseases such as Attention Deficit Hyperactivity Disorder, Cancer, and Food Allergy.